Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

959 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.
DiNardo CD, Schuh AC, Stein EM, Montesinos P, Wei AH, de Botton S, Zeidan AM, Fathi AT, Kantarjian HM, Bennett JM, Frattini MG, Martin-Regueira P, Lersch F, Gong J, Hasan M, Vyas P, Döhner H. DiNardo CD, et al. Among authors: kantarjian hm. Lancet Oncol. 2021 Nov;22(11):1597-1608. doi: 10.1016/S1470-2045(21)00494-0. Epub 2021 Oct 18. Lancet Oncol. 2021. PMID: 34672961 Clinical Trial.
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy.
Ramos Perez JM, Patel KP, Loghavi S, Garcia-Manero G, Borthakur G, Jabbour E, Wierda W, Pierce S, Brandt M, Kornblau S, Kadia T, Daver N, DiNardo CD, Jain N, Yilmaz M, Short N, Verstovsek S, Ferrajoli A, Andreeff M, Konopleva M, Rivera D, McCue D, Kantarjian HM, Ravandi F. Ramos Perez JM, et al. Among authors: kantarjian hm. Leuk Lymphoma. 2021 Oct 20:1-4. doi: 10.1080/10428194.2021.1992757. Online ahead of print. Leuk Lymphoma. 2021. PMID: 34668451
The cure of leukemia through the optimist's prism.
Kantarjian HM, Jain N, Garcia-Manero G, Welch MA, Ravandi F, Wierda WG, Jabbour EJ. Kantarjian HM, et al. Cancer. 2021 Oct 6. doi: 10.1002/cncr.33933. Online ahead of print. Cancer. 2021. PMID: 34614211 Review.
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.
Issa GC, Zarka J, Sasaki K, Qiao W, Pak D, Ning J, Short NJ, Haddad F, Tang Z, Patel KP, Cuglievan B, Daver N, DiNardo CD, Jabbour E, Kadia T, Borthakur G, Garcia-Manero G, Konopleva M, Andreeff M, Kantarjian HM, Ravandi F. Issa GC, et al. Among authors: kantarjian hm. Blood Cancer J. 2021 Sep 29;11(9):162. doi: 10.1038/s41408-021-00557-6. Blood Cancer J. 2021. PMID: 34588432 Free PMC article.
Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience.
Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Haddad FG, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Konopleva MY, Daver NG, Kadia TM, Garcia-Manero G, Garris R, O'Brien SM, Jabbour EJ. Richard-Carpentier G, et al. Among authors: kantarjian hm. Blood Adv. 2021 Sep 15:bloodadvances.2021004580. doi: 10.1182/bloodadvances.2021004580. Online ahead of print. Blood Adv. 2021. PMID: 34525185 Free article.
Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine.
Venugopal S, Maiti A, DiNardo CD, Qiao W, Ning J, Loghavi S, Daver NG, Kadia TM, Rausch CR, Alvarado Y, Ohanian M, Sasaki K, Short NJ, Takahashi K, Yilmaz M, Ravandi F, Kantarjian HM, Konopleva MY. Venugopal S, et al. Among authors: kantarjian hm. Leuk Lymphoma. 2021 Sep 3:1-5. doi: 10.1080/10428194.2021.1973675. Online ahead of print. Leuk Lymphoma. 2021. PMID: 34474640 No abstract available.
959 results